4//SEC Filing
Azamian Bobak R. 4
Accession 0001819790-25-000110
CIK 0001819790other
Filed
Aug 12, 8:00 PM ET
Accepted
Aug 13, 4:32 PM ET
Size
5.7 KB
Accession
0001819790-25-000110
Insider Transaction Report
Form 4
Azamian Bobak R.
DirectorPresident/CEO and Board Chair
Transactions
- Sale
Common Stock
2025-08-11$50.00/sh−6,000$300,000→ 818,106 total(indirect: By Trust)
Holdings
- 53,635
Common Stock
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2024.
- [F2]The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares.
Documents
Issuer
Tarsus Pharmaceuticals, Inc.
CIK 0001819790
Entity typeother
Related Parties
1- filerCIK 0001827672
Filing Metadata
- Form type
- 4
- Filed
- Aug 12, 8:00 PM ET
- Accepted
- Aug 13, 4:32 PM ET
- Size
- 5.7 KB